Join us for a online event that focuses on Women in Multiple Sclerosis (MS). This webinar will provide valuable insights and information about the unique challenges and experiences faced by women with MS. Gain knowledge from renowned experts in the field and hear inspiring stories from women who are managing their MS. Don't miss [...]
On the occasion of Multiple Sclerosis Awareness Week 2022, the national extension of the virtual exhibition "Living with MS during COVID-19: A case for rethinking MS care in the EU" brings light to the impact of the COVID-19 pandemic on multiple sclerosis at country level. Impact of the COVID-19 pandemic on multiple sclerosis at [...]
The EMSP Annual Conference 2022 will take place on 29-30 April 2022 in hybrid format, virtually and in person in Madrid, Spain. The theme of this year’s conference is ”A Holistic Approach for Personalised MS Care”. The personalised care model seeks to deliver whole-population approaches to support people of all ages and their carers to [...]
The European Brain Council is pleased to invite you to register for the digital event "Best practices for patient safety: An EU-wide view on the use of medicines off-label" to be held virtually on 30 November 2021 at 14:30 - 16:00 CET. In 2016, the Declaration for Good Off-Label Use Practice was launched, supported by a [...]
On the occasion of the approaching World Multiple Sclerosis Day (30 May 2021), the European Brain Council is excited to announce the release of its new policy paper, "RETHINKING MS in times of COVID-19". This new paper is part of the main report "RETHINKING MS in Europe", a research-driven project offering tangible policy changes [...]
The European Brain Council is pleased to invite you to register for the digital event "Patient safety and informed consent: The importance of good off-label use practices" to be held virtually on 17 June 2021 at 14:30 - 16:00CET. The event is co-organised with EUCOPE. In 2016, the Declaration for Good Off-Label Use Practice was launched, supported [...]
The rapid development of COVID-19 vaccines is perhaps the clearest example of cumulative medical innovationㅡand its undisputed power to transform lives. But scientific innovation has not been limited to the race for immunity. From telemedicine and portable diagnostics to digital therapeutics and blockchain, digital technologies are reshaping health-care delivery―and could play a transformative role [...]
The European Brain Council (EBC) is pleased to invite you to register & attend the digital event "Brain and machine: Improving MS care in a digital age", to be held virtually on 27 May 2021 at 11:00 CET. The event is supported by Biogen, EBC and EU40. The rapid development of COVID-19 vaccines is perhaps [...]
After years of work, the outcomes of the MULTI-ACT project will be presented at the Final Conference, “The MULTI-ACT model: the path forward for participatory governance in health research and innovation”, to be held virtually on 23 March 2021 at 14:00-17:00. The EU-funded MULTI-ACT project aims to increase the impact of health research on [...]
Just over a month ago, EBC published its statement on the impact of COVID-19 on brain health, hoping that the growing evidence of the long-term effects of the disease would be taken into account in the planning for post-pandemic recovery at the EU and national levels. It continues to grow more evident that COVID-19 has [...]
